CIBC Private Wealth Group
XERS icon

CIBC Private Wealth Group’s Xeris Biopharma Holdings XERS Stock Holding History

CIBC Private Wealth Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$52.3K Hold
6,664
– – ﹤0.01% 1760
2025
Q3 		$54.2K Hold
6,664
– – ﹤0.01% 1755
2025
Q2 		$31.1K Hold
6,664
– – ﹤0.01% 1850
2025
Q1 		$27.5K Hold
6,664
– – ﹤0.01% 1873
2024
Q4 		$22.4K Hold
6,664
– – ﹤0.01% 2008
2024
Q3 		$19K Sell
6,664
-1,000
-13% -$2.57K ﹤0.01% 2181
2024
Q2 		$16.3K Buy
7,664
+2,000
+35% +$4.03K ﹤0.01% 2106
2024
Q1 		$12.1K Buy
+5,664
New +$14.7K ﹤0.01% 2204

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIBC Private Wealth Group's XERS Position: Q4 2025 in Review

CIBC Private Wealth Group held its Xeris Biopharma Holdings (XERS) position steady in Q4 2025 at 6,664 shares worth $52.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1760.

CIBC Private Wealth Group first reported a position in XERS in Q1 2024 and has held it in 8 quarters since. The position peaked at $54.2K in Q3 2025. 225 funds tracked by Wall St. Rank hold XERS as of Q4 2025.

  • CIBC Private Wealth Group held 6,664 shares of Xeris Biopharma Holdings worth $52.3K as of Q4 2025.
  • CIBC Private Wealth Group left its Xeris Biopharma Holdings share count unchanged in Q4 2025.
  • Xeris Biopharma Holdings made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1760 holding.
  • CIBC Private Wealth Group first reported a position in Xeris Biopharma Holdings in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's Xeris Biopharma Holdings position peaked at $54.2K in Q3 2025.
  • 225 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.